Ajovy bags NICE approval by Anna Smith | Mar 12, 2020 | News | 0 The anti-CGRP preventive therapy is the first of-its-kind to be recommended by NICE. Read More
Teva’s anti-CGRP drug Ajovy cleared for migraine prevention by Selina McKee | Sep 17, 2018 | News | 0 US regulators have approved Teva’s Ajovy for the preventative treatment of migraine in adults. Read More
Teva’s anti-CGRP drug under review for migraine by Selina McKee | Dec 19, 2017 | News | 0 US regulators are now reviewing Teva Pharmaceutical’s experimental anti-CGRP therapy fremanezumab for the preventive treatment of migraine, and have also granted the drug a fast track designation for the prevention of cluster headache. Read More